Approvals/CIMA-AEMPS/RANOLAZINA TEVA 375 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Approved

STANDARD

RANOLAZINA TEVA 375 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Teva Pharma S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: ec02ca84552f2e90
Drug Cima Aemps Name: RANOLAZINA TEVA 375 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number: 89226
Holder Company Name: Teva Pharma S.L.U.
Marketing Company Name: Teva Pharma S.L.U.
Authorization Date: 2024-01-09
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 375 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva Pharma S.L.U.

RANOLAZINA

375 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 9, 2024

Approval ID

ec02ca84552f2e90

Type

Standard